Preferences on the uptake and completion of single- or three-dose regimen of benzathine penicillin G injection for the treatment of late syphilis: a discrete-choice experiment
Sexual Health · 2025
DOI: 10.1071/sh25044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sexual Health, 2025. Verfasst von Nang Nge Nge Phoo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Curtin School of Population Health, Faculty of Health Sciences, Curtin University, Perth, WA, Australia. Hauptthemen laut MEDLINE: Penicillin G Benzathine, Anti-Bacterial Agents, Patient Preference, Syphilis, Latent. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Notifications of syphilis in Australia have increased since 2011, particularly among gay and bisexual men who have sex with men (GBMSM). Adherence to current late latent syphilis treatment regimen is low-moderate, which is a significant health issue. To address this treatment non-compliance, a single high-dose benzathine benzylpenicillin G regimen has been under clinical trial. This study aimed to determine which attributes of either a three-dose or single-dose benzathine benzylpenicillin G regimen for treating late latent syphilis were preferred, and which attributes were deemed most important by a sample of GBMSM in Australia.
Methods
A discrete-choice experiment survey was administered to GBMSM. This included two experiments: (1) treatment Day 1, and (2) completion of a full course. Random parameters logit model and latent class analysis were used to analyse choices of preferred attribute levels, and attributes deemed most important by respondents.
Results
A total of 309 respondents completed the survey, having a mean age of 42.35 (±15.4) years. The choices revealed respondents’ preferred attribute levels that were related to the single high-dose regimen, such as one injection on Day 1, the use of a shorter and thinner needle, a single injection, and a single appointment to complete the treatment course. Respondents preferred a shorter injection time. The pain on treatment Day 1, and the total number of injection(s) and appointment(s) to complete a treatment course were of most concern to respondents.
Conclusions
The GBMSM respondents preferred one injection and one appointment for a full treatment course, which supports efforts to develop a single high-dose benzathine benzylpenicillin G regimen for late latent syphilis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Curtin School of Population Health, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
- WAAC, Perth, WA, Australia.
- School of Translational Medicine, Monash University, Melbourne, Vic, Australia.
- Melbourne Sexual Health Centre, Melbourne, Vic, Australia.
- The University of Western Australia, Perth, WA, Australia.
- The Kids Research Institute Australia, Perth, WA, Australia.
ORCID-Profile: Nang Nge Nge Phoo, Jason J Ong, Thel Hla, Jonine Jancey
Zitieren
APA
Phoo, N. N. N., Norman, R., Vujcich, D., Ong, J. J., Manning, L., Tobin, R., Hla, T., & Jancey, J. (2025). Preferences on the uptake and completion of single- or three-dose regimen of benzathine penicillin G injection for the treatment of late syphilis: a discrete-choice experiment. Sexual Health. https://doi.org/10.1071/sh25044
Vancouver
Phoo NNN, Norman R, Vujcich D, Ong JJ, Manning L, Tobin R, et al. Preferences on the uptake and completion of single- or three-dose regimen of benzathine penicillin G injection for the treatment of late syphilis: a discrete-choice experiment. Sexual Health. 2025. doi:10.1071/sh25044
BibTeX
@article{Phoo2025,
author = {Phoo, Nang Nge Nge and Norman, Richard and Vujcich, Daniel and Ong, Jason J and Manning, Laurens and Tobin, Rochelle and Hla, Thel and Jancey, Jonine},
title = {Preferences on the uptake and completion of single- or three-dose regimen of benzathine penicillin G injection for the treatment of late syphilis: a discrete-choice experiment},
journal = {Sexual Health},
year = {2025},
doi = {10.1071/sh25044}
}
EUVIMED